Latest news
Loading news…
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
AVEO Oncology was acquired by LG Chem in 2022 for $566M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
208
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cambridge, Massachusetts, United States
- Diversity spotlight
- Women Founded
Key People at AVEO Oncology
Co - Founder & Board of Directors
Chief Medical Officer and Formation of Scientific Advisory Committee
208
professional contacts at AVEO Oncology
Contact execs at AVEO Oncology →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to AVEO Oncology
Loading news…
FAQs about AVEO Oncology
People who checked this page also checked these
Browse the full Acquirezy directory.